Zeynab Yassin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Pseudomonas Aeruginosa

Cerebrospinal Fluid

Top Venues

Archives of Iranian medicine

Journal of medical case reports

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Parisa Mashayekhi, Mir Davood Omrani, Zeynab Yassin, Ali Dehghanifard, Leila Ashouri, Sara Sadat Aghabozorg Afjeh, Zahra Shabanzadeh
Influence of HLA-A, -B, -DR Polymorphisms on the Severity of COVID-19: A Case-Control Study in the Iranian Population. Archives of Iranian medicine 26 (5) (2023)
Parisa Mashayekhi, Mir Davood Omrani, Zeynab Yassin, Ali Dehghanifard, Leila Ashouri, Sara Sadat Aghabozorg Afjeh, Zahra Shabanzadeh
Influence of HLA-A, -B, -DR Polymorphisms on the Severity of COVID-19: A Case-Control Study in the Iranian Population. Archives of Iranian medicine 26 (5) (2023)
Zeynab Yassin, Armita Farid, Sayedali Ahmadi, Maziar Emamikhah, Omid Motamedi, Mohammadamin Jafari, Azadeh Goodarzi
Coronavirus disease 2019 (COVID-19)-associated brain abscesses caused by Pseudomonas aeruginosa and Aspergillus fumigatus: two case and a review of the literature. Journal of medical case reports 17 (1) (2023)
Parisa Mashayekhi, Mir Davood Omrani, Zeynab Yassin, Ali Dehghanifard, Leila Ashouri, Sara Sadat Aghabozorg Afjeh, Zahra Shabanzadeh
Influence of HLA-A, -B, -DR Polymorphisms on the Severity of COVID-19: A Case-Control Study in the Iranian Population. Archives of Iranian medicine 26 (5) (2023)
Parisa Mashayekhi, Mir Davood Omrani, Zeynab Yassin, Ali Dehghanifard, Leila Ashouri, Sara Sadat Aghabozorg Afjeh, Zahra Shabanzadeh
Influence of HLA-A, -B, -DR Polymorphisms on the Severity of COVID-19: A Case-Control Study in the Iranian Population. Archives of Iranian medicine 26 (5) (2023)
Saeed Kalantari, Soheil R Fard, Donya Maleki, Mahshid T Taher, Zeynab Yassin, Yousef Alimohamadi, Sara Minaeian
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients. Journal of medical virology 93 (12) (2021)